Abstract:OBJECTIVE:To explore the correlation of chemokines and chemokine receptors with clinical features of newly diagnosed systemic lupus erythematosus (SLE). METHODS:Samples of venous blood were collected from 37 newly diagnosed SLE patients, 2 males and 35 females, aged 32.5 (15-54), and 20 healthy controls. The serum concentration of macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta and reduced upon activation normal T cell expressed and secreted (RANTES) were measured by ELISA. Samples of anticoagulative serum were collected from 18 of the 37 newly diagnosed SLE patients and 10 healthy controls. The expression rates of CCR1, CCR3, and CCR5 on CD4+ T cells were detected by flow cytometry. Indirect immunofluorescence method was used to detect the anti-ds-DNA antibody, and blot immunoassay was used to detect the anti-RNP and anti-SSA antibodies. The associations of chemokines and chemokine receptors with the clinical features were analyzed. RESULTS:The serum concentration of MIP-1alpha of the SLE patients was (37 +/- 25) ng/L, significantly higher than that of the controls (8 +/- 9) ng/L (P < 0.001). The serum concentration of MIP-1beta of the SLE patients was (160 +/- 140) ng/L, significantly higher than that of the controls (76 +/- 41) ng/L (P = 0.003). The serum concentration of RANTES of the SLE patients was (184 +/- 22) ng/L, not significantly different from that of the controls (144 +/- 79) ng/L (P > 0.05). The serum concentration of MIP-1alpha of the SLE patients with fever was 52 ng/L +/- 27 ng/L, significantly higher than that of the SLE patients without fever (28 ng/L +/- 19 ng/L, P = 0.006). The serum concentration of MIP-1beta of the SLE patients with arthritis was 221 ng/L +/- 158 ng/L, significantly higher than that of the SLE patients without arthritis (95 ng/L +/- 83 ng/L, P = 0.008). The serum concentration of RANTES of the SLE patients with low blood platelet count was 130 ng/L +/- 122 ng/L, significantly lower than that of the SLE patients with normal blood platelet count (212 ng/L +/- 114 ng/L, P = 0.049). The percentage of CD4+ CCR3+ T cell subgroup in CD4+ T cell in peripheral blood of the SLE patients positive in anti-RNP antibody was 14.8% +/- 3.0%, significantly lower than that of the SLE patients negative in anti-RNP antibody (11.3% +/- 2.6%, P = 0.018). CONCLUSION:Abnormality of different chemokines and chemokine receptors may concern with different clinical features of SLE.

Research progress of chemotactic factor CXCL12/SDF-1 and its receptor CXCR4 and systemic lupus erythemato-sus(sle)

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Progress of the relationship of regulatory T cells and human systemic lupus erythematosus

lncRNA X-inactive-specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic lupus erythematosus

Chemokines and chemokine receptors: Potential therapeutic targets in systemic lupus erythematosus

The expression rate of chemokine receptors on CD4~+ T cells and its pathogenic roles in new-onset systemic lupus erythematosus

Expression of chemokine receptors CX3CR1 mRNA in patients with systemic lupus erythematosus

The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease

Role of the CXCR6/CXCL16 axis in autoimmune diseases

Correlation of Chemokines and Chemokine Receptors with Clinical Features in Newly Diagnosed Systemic Lupus Erythematosus

Studies on Expression of Chemokine Receptors CCR4 and CCR5 Mrna in Patients with Systemic Lupus Erythematosus

Chemokines and lymphocyte homing in Sjögren's syndrome

CXCL13, CCL4, and Stnfr As Circulating Inflammatory Cytokine Markers in Primary and SLE-related Autoimmune Hemolytic Anemia

The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity

Associations of Circulating CXCR3–PD-1+CD4+T Cells with Disease Activity of Systemic Lupus Erythematosus

Correlation of chemokines and chemokine receptors with immunological abnormality in newly diagnosed systemic lupus erythemtosus patients

Identification and Characterization of CD8+CD27+CXCR3− T Cell Dysregulation and Progression‐Associated Biomarkers in Systemic Lupus Erythematosus

Relevance of the chemokine CXCL12/CXCR7 axis in cardiovascular disease

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

Th1-related transcription factors and cytokines in systemic lupus erythematosus